|
|
Mental Disease Therapeutic Market Research
 | |  |
| |
Global Information, Inc. offers market intelligence on every topic in the Mental Disease Therapeutic, including, but not limited to market trend on Therapeutic of: Antidepressant; Psychiatric Disorder; Insomnia; Neurodegenerative; Antianxiety; Antipsychotics; Alzheimer; Psychiatry; PTSD.
We offer market research, industry forecasts, and business analysis in the Mental Disease Therapeutic as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.
|
|
 | |  |
Reports
| Central Nervous System Alzheimer Disease |
|
| Published : 2008/03 |
| Life Science Analytics' , Central Nervous System Alzheimer Disease contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the late ... |
| Central Nervous System Anxiety |
|
| Published : 2008/03 |
| Life Science Analytics' , Central Nervous System Anxiety contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news an ... |
| Central Nervous System Attention Deficit Disorder with Hyperactivity |
|
| Published : 2008/03 |
| Life Science Analytics' , Central Nervous System Attention Deficit Disorder with Hyperactivity contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as w ... |
| Central Nervous System Dementia |
|
| Published : 2008/03 |
| Life Science Analytics' , Central Nervous System Dementia contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news a ... |
| Central Nervous System Depression |
|
| Published : 2008/03 |
| Life Science Analytics' , Central Nervous System Depression contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news ... |
| Central Nervous System Epilepsy |
|
| Published : 2008/03 |
| Life Science Analytics' , Central Nervous System Epilepsy contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news a ... |
| Central Nervous System Headache |
|
| Published : 2008/03 |
| Life Science Analytics' , Central Nervous System Headache contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news a ... |
| Central Nervous System Insomnia or Sleep Disorders |
|
| Published : 2008/03 |
| Life Science Analytics' , Central Nervous System Insomnia or Sleep Disorders contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary o ... |
| Central Nervous System Memory Impairment |
|
| Published : 2008/03 |
| Life Science Analytics' , Central Nervous System Memory Impairment contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the late ... |
| Central Nervous System Migraine |
|
| Published : 2008/03 |
| Life Science Analytics' , Central Nervous System Migraine contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news a ... |
| Central Nervous System Multiple Sclerosis |
|
| Published : 2008/03 |
| Life Science Analytics' , Central Nervous System Multiple Sclerosis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the lat ... |
| Central Nervous System Neuropathy |
|
| Published : 2008/03 |
| Life Science Analytics' , Central Nervous System Neuropathy contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news ... |
| Central Nervous System Pain |
|
| Published : 2008/03 |
| Life Science Analytics' , Central Nervous System Pain contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and d ... |
| Central Nervous System Parkinson Disease |
|
| Published : 2008/03 |
| Life Science Analytics' , Central Nervous System Parkinson Disease contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the late ... |
| Central Nervous System Psychotic Disorders |
|
| Published : 2008/03 |
| Life Science Analytics' , Central Nervous System Psychotic Disorders contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the la ... |
| Central Nervous System Schizophrenia |
|
| Published : 2008/03 |
| Life Science Analytics' , Central Nervous System Schizophrenia contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest n ... |
| Central Nervous System Seizures |
|
| Published : 2008/03 |
| Life Science Analytics' , Central Nervous System Seizures contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news a ... |
| Central Nervous System Stroke |
|
| Published : 2008/03 |
| Life Science Analytics' , Central Nervous System Stroke contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and ... |
| Peripheral Neuropathy and Neuropathic Pain, 2008 |
|
| Published : 2008/01 |
| This report estimates that Peripheral Neuropathy (PN) and Neuropathic Pain (NP) affect 170 to 270 million individuals globally. PN and NP are causally linked to a number of diseases, however diabetes, cancer and HIV alone are expected to increase the prev ... |
| Advances in Neurostimulators |
|
| Published : 2007/06 |
| This research service analyses the critical trends and advancements made in neurostimulators. ... |
| CNS Market Trends, 2007 to 2010 |
|
| Published : 2007/06 |
| The global market for drugs treating Central Nervous System (CNS) disorders has grown rapidly in recent years to reach US$55.5 billion in 2005, a year-on-year increase of 6.6%. ... |
| Rimonabant: The first of the Cannabinoid blockbusters |
|
| Published : 2007/06 |
| The report provides in-depth market analysis for current and potential products. The report extensively identifies cannabinoid drugs market potential by analysing the latest clinical trial research and highlighting new indications. ... |
| European Neurophysiological Monitors Market |
|
| Published : 2007/04 |
| This research service analyses the neurophysiological monitors market in Europe; identifies the drivers, restraints and challenges in the market, provides revenue forecasts and strategic recommendations for growth. ... |
| Atypical Antipsychotics: Life-Cycle Management and Future Trends |
|
| Published : 2006/12 |
| The $15 billion antipsychotics market will be hard hit by generics of nearly all the most frequently prescribed atypicals and by a dearth of breakthrough therapies in the pipeline. Overall market decline will be signifi cant by 2015, but current market le ... |
| European Antidepressants Markets |
|
| Published : 2006/06 |
| This Frost & Sullivan research service titled European Antidepressants Markets provides a detailed analysis of the antidepressants markets, with a description of key market drivers and restraints. An analysis of the product pipelines of leading companies ... |
Annual Information Services
| The Outlook for Pharmaceuticals in Latin America to 2012 |
|
|
| Each country report provides a comprehensive analysis of the pharmaceutical market, including five-year market forecasts. For each country you will receive 4 completely updated reports sent quarterly, plus comprehensive report sent annually. ... |
|
|
View Cart
